Taysha Gene Therapies (TSHA) PT Raised to $13 at Goldman Sachs
Tweet
Share
E-mailGet Alerts TSHA Hot Sheet
Price: $5.83 +3.00%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 22 | New: 24
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 22 | New: 24
Join SI Premium – FREE
Goldman Sachs analyst Salveen Richter raised the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $13.00 (from $11.00) while maintaining a Buy rating.
You May Also Be Interested In
- Cantor Fitzgerald Downgrades DOMO (DOMO) to Neutral
- Norfolk Southern (NSC) PT Raised to $358 at Evercore ISI
- Rush Street Interactive (RSI) PT Raised to $35 at Benchmark
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
